Description of the plasminogen activating system in canine gingival crevicular fluid

Abstract Summary Objective : Human gingival crevicular fluid (GCF) contains fibrinolytic activity, which has been suggested to be of significance for the etiology of periodontal diseases. We have previously found plasminogen activators (u-PA and t-PA) as well as PA inhibitors (PAI -1 and PAI-2) in human GCF and gingival tissues. The aim of this study was to evaluate the dog as an experimental animal for studying the fibrinolytic system (the plasminogen activating system) with available reagents and to describe the system in dog cr evicular fluid. Design : Six dogs were used. Samples from untreated gingival areas showing chronic gingivitis were collected with disks of Millipore filter. Fibrinolytic activity was assayed using a preformed fibrin gel in microtiter plates. t-PA as well as PAI-2 were assayed with ELISAs and Western blotting using antibodies against human antigens. Results : All samples showed fibrinolytic activity. The fibrinolytic activity could be completely quenched by antibodies against human t-PA. Antigen concentrations were similar to those found in humans; the median t-PA concentration in GCF from chronic gingivitis was 0.1μg/ml and the median PAI-2 concentration was 1.6μg/ml. Western blotting showed bands in the same kDa positions as for human t-PA and PAI-2. As in humans, both antibodies also revealed high-molecular-weight bands of similar size (130 kDa), which are likely to represent a complex between t-PA and PAI-2. Conclusion : Our results clearly show that the cross-reactivity is genuine and that these antibodies, developed against human antigens, can be used for experimental studies in the dog.

[1]  L. Matsson,et al.  Localization of plasminogen activators and plasminogen-activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization. , 1999, Archives of oral biology.

[2]  B. Nielsen,et al.  Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[3]  R. Lavker,et al.  Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[4]  A. Lanevschi,et al.  Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs. , 1996, American journal of veterinary research.

[5]  L. Matsson,et al.  Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. , 1996, Journal of periodontal research.

[6]  J. Brown,et al.  Molecular characterization of plasminogen activators in human gingival crevicular fluid. , 1995, Archives of oral biology.

[7]  J. Jespersen,et al.  Plasminogen activator activity and plasma-coagulum lysis measured by use of optimized fibrin gel structure preformed in microtiter plates. , 1995, Clinical chemistry.

[8]  M. Kramer,et al.  Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. , 1995, Biological chemistry Hoppe-Seyler.

[9]  L. Matsson,et al.  The plasminogen-activating system in gingival fluid from adults. An intra-individual study before and after treatment of gingivitis. , 1994, Scandinavian journal of dental research.

[10]  P. Quax,et al.  Plasminogen activators are involved in keratinocyte and fibroblast migration in wounded cultures in vitro , 1994 .

[11]  L. Lund,et al.  The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during re-epithelialization of mouse skin wounds. , 1994, The Journal of investigative dermatology.

[12]  L. Granath,et al.  Tissue plasminogen activator (t-PA) and placental plasminogen activator inhibitor (PAI-2) in gingival fluid from 8-9-year-old children. , 1993, Scandinavian journal of dental research.

[13]  J. Brown,et al.  Plasminogen Activator in Periodontal Health and Disease , 1992, Annals of the New York Academy of Sciences.

[14]  L. Matrisian The matrix‐degrading metalloproteinases , 1992, Journal of neuro-oncology.

[15]  B. Åstedt,et al.  Tissue plasminogen activator and placental plasminogen activator inhibitor in human gingival fluid , 1991 .

[16]  B. Klinge,et al.  Clinical and histological findings in ligature-induced experimental periodontitis in dogs. A pilot study. , 1990, Journal of clinical periodontology.

[17]  P. Hart,et al.  Human monocytes can produce tissue-type plasminogen activator , 1989, The Journal of experimental medicine.

[18]  J. Davidson Fundamental and clinical fibrinolysis: Edited by F. J. Castellino, P. J. Gafney, M. M. Samama, A. Takada. Exerpta Medica, Amsterdam, 1987. pp 234 , 1988 .

[19]  C. Kluft,et al.  Plasminogen activator inhibitors. , 1987, Blood.

[20]  I. Hägerstrand,et al.  Cellular Localisation in Placenta of Placental Type Plasminogen Activator Inhibitor , 1986, Thrombosis and Haemostasis.

[21]  H. Chapman,et al.  Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor. , 1985, Biochemical Journal.

[22]  A. Vaheri,et al.  Urokinase‐type plasminogen activator and its inhibitor secreted by cultured human monocyte‐macrophages , 1985, Journal of cellular physiology.

[23]  D. Belin,et al.  Concomitant secretion of prourokinase and of a plasminogen activator- specific inhibitor by cultured human monocytes-macrophages , 1984, The Journal of experimental medicine.

[24]  L. Häggroth,et al.  Inhibition of the human tissue plasminogen activator in plasma from different species. , 1984, Thrombosis research.

[25]  K. Maeda,et al.  Fibrinolytic activity in periodontal disease. The relationship between fibrinolytic activity and severity of periodontal disease. , 1981, Journal of periodontology.

[26]  L. Matsson,et al.  Development of experimental gingivitis in the juvenile and adult beagle dog. , 1979, Journal of clinical periodontology.

[27]  Z. Werb,et al.  Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. , 1977, The New England journal of medicine.

[28]  J. Lindhe,et al.  Experimental periodontal breakdown in the dog. , 1975, Scandinavian journal of dental research.

[29]  H. Löe,et al.  Experimental periodontitis in the beagle dog. , 1973, Journal of periodontal research.

[30]  H Löe,et al.  The Gingival Index, the Plaque Index and the Retention Index Systems. , 1967, Journal of periodontology.

[31]  J. Egelberg,et al.  The blood vessels of the dento-gingival junction. , 1966, Journal of periodontal research.

[32]  I. Nilsson,et al.  Fibrinolytic Activity in Fluid from Gingival Crevice.∗ , 1961, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[33]  R. Cohen,et al.  Plasminogen activator in human periodontal health and disease. , 1991, Archives of oral biology.

[34]  B. Åstedt,et al.  Occurrence of a specific plasminogen activator inhibitor of placental type, PAI-2, in men and non-pregnant women , 1989 .

[35]  B. Åstedt,et al.  No crossreaction between circulating plasminogen activator and urokinase. , 1979, Thrombosis research.